Loading...
Loading...
Among the 8 tracked institutional investors we monitor, VIR (VIR BIOTECHNOLOGY INC) is held with a combined value of $367.93M across 45,167,049 shares. The largest holder is BlackRock, Inc. with a position worth $161.27M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 5 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$367.93M
Total Shares Held
45,167,049
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $161.27M | 0.00% | +10.2% |
| 2 | VANGUARD GROUP INC | $75.67M | 0.00% | New |
| 3 | STATE STREET CORP | $63.98M | 0.00% | +14.6% |
| 4 | CITADEL ADVISORS LLC | $19.75M | 0.00% | +305.2% |
| 5 | FMR LLC | $18.56M | 0.00% | -34.4% |
| 6 | Point72 Asset Management, L.P. | $17.49M | 0.02% | +897.5% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | $6.82M | 0.01% | +23.9% |
| 8 | MILLENNIUM MANAGEMENT LLC | $4.38M | 0.00% | -51.2% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of VIR with a position worth $161.27M, representing 0.00% of their portfolio. In total, 8 institutional investors hold VIR with a combined value of $367.93M.
In the most recent quarter, 1 fund opened a new position in VIR. Additionally, 5 increased their holdings and 2 reduced their positions.
Institutional investors hold $367.93M worth of VIR stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $161.27M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For VIR, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their VIR positions.